Status: Not yet recruiting
Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern Hemisphere
The study is designed as a clinical feasibility, to investigate the positive and negative percent agreement (PPA and NPA) of the BinaxNOW™ COVID-19/Flu A\&B Combo against a highly sensitive PCR method(s) in symptomatic patients suspected of SARS-CoV-2 or influenza infection when nasal swabs are self-collected by the patient/lay user.
Participants needed: 700
Trial details
Age: 2+Biological sex: AllType: InterventionalSponsor: Abbott Rapid DxUpdated: Apr 15, 2025
Eligibility criteria
Participant is at least two (2) years of age, AND Participant is suspected of ac... [+1]
Participant is currently enrolled in a study to evaluate an investigational drug... [+7]